GE HealthCare Technologies GEHC
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
GE HealthCare Technologies (GEHC) Core Market Data and Business Metrics
Latest Closing Price
$79.36Price-Earnings Ratio
18.29Total Outstanding Shares
457.30 Million SharesDividend
$0.04 Per Share QuarterlySIC Description
X-ray Apparatus & Tubes & Related Irradiation ApparatusPrimary Exchange
NASDAQHeadquarters
500 West Monroe Street, Chicago, IL, 60661
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
---|---|---|---|
3,752,366 Shares | 2.61 | 3/14/2025 | 9,811,835 Shares |
2,943,582 Shares | 3.42 | 2/28/2025 | 10,068,005 Shares |
3,138,522 Shares | 2.94 | 2/14/2025 | 9,238,261 Shares |
2,103,159 Shares | 4.61 | 1/31/2025 | 9,688,431 Shares |
3,353,367 Shares | 3.8 | 1/15/2025 | 12,755,443 Shares |
3,127,719 Shares | 3.89 | 12/31/2024 | 12,153,444 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Net Cash Flow From Operating Activities, Continuing | $1.96 Billion |
Net Cash Flow From Investing Activities | $-914 Million |
Net Cash Flow | $387 Million |
Net Cash Flow From Operating Activities, Discontinued | $-4 Million |
Net Cash Flow From Financing Activities | $-573 Million |
Exchange Gains/Losses | $-77 Million |
Income Statement
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Net Income/Loss Available To Common Stockholders, Basic | $1.99 Billion |
Income/Loss From Continuing Operations After Tax | $2.05 Billion |
Costs And Expenses | $17.09 Billion |
Basic Average Shares | $456 Million |
Selling, General, and Administrative Expenses | $4.27 Billion |
Revenues | $19.67 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Other Comprehensive Income/Loss | $-691 Million |
Other Comprehensive Income/Loss Attributable To Parent | $-688 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $53 Million |
Other Comprehensive Income/Loss Attributable To Noncontrolling Interest | $-4 Million |
Comprehensive Income/Loss | $1.36 Billion |
Comprehensive Income/Loss Attributable To Parent | $1.31 Billion |
Balance Sheet
January 1, 2024 to December 31, 2024
Metric | Value |
---|---|
Redeemable Noncontrolling Interest | $188 Million |
Inventory | $1.94 Billion |
Liabilities | $24.44 Billion |
Noncurrent Liabilities | $14.88 Billion |
Equity Attributable To Parent | $8.45 Billion |
Liabilities And Equity | $33.09 Billion |
Historical Dividends
Current dividend: $0.04 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Mar 27, 2025 | May 15, 2025 | Apr 25, 2025 | $0.035 | Quarterly |
Nov 21, 2024 | Feb 14, 2025 | Jan 14, 2025 | $0.035 | Quarterly |
Sep 18, 2024 | Nov 15, 2024 | Oct 18, 2024 | $0.03 | Quarterly |
Jun 26, 2024 | Aug 15, 2024 | Jul 19, 2024 | $0.03 | Quarterly |
Mar 22, 2024 | May 15, 2024 | Apr 19, 2024 | $0.03 | Quarterly |
Dec 8, 2023 | Feb 15, 2024 | Jan 16, 2024 | $0.03 | Quarterly |